The Home Infusion Therapy Market To Be In Sync With Technology, Reach US$ 26,747

Posted by Ashish on January 11th, 2021

According to a new market report published by Persistence Market Research “Global Market Study on Home Infusion Therapy Devices – Needleless Connectors to Witness Highest Growth by 2020”, the global home infusion therapy devices market was valued at US$ 15,905.1 Mn in 2014 and is expected to grow at a CAGR of 9% from 2014 to 2020, to reach US$ 26,747.8 Mn by 2020.

Home infusion therapy facilitates intravenous at-home administration of medicines into the patient’s body through needle and catheter. The therapy is prescribed by physicians and administered by trained healthcare professionals. It is used when oral medication is not effective for the treatment of diseases such as cancer and gastrointestinal diseases.

 Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/2893

Some of the major players in the home infusion therapy devices market:

•     Hospira, Inc.
•     B. Braun Melsungen AG.
•     Caesarea Medical Electronics.
•     Fresenius Kabi AG.
•     Smiths Medical.
•     CareFusion Corporation.
•     ICU Medical, Inc.
•     JMS Co. Ltd.
•     Baxter.
•     Terumo Corporation.